FDA Adverse Event Malfunction Summary report: N

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

MDR report key: 4780678 · Received May 19, 2015

Report

Report Number
3004209178-2015-57382
Event Type
Malfunction
Date Received
May 19, 2015
Date of Event
April 28, 2015
Report Date
April 28, 2015
Manufacturer
MEDTRONIC PUERTO RICO OPERATIONS CO.
Product Code
OYC
PMA / PMN Number
P980022
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT. THE DEVICE HAS BEEN RETURNED, BUT NOT YET EVALUATED. FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME.

Additional Manufacturer Narrative · 1

THE INSULIN PUMP WAS UNABLE TO PRIME DURING THE PRIME TEST AND MOTOR ERROR DURING THE BASIC OCCLUSION TEST DUE TO PROTRUDED/LOOSE DRIVE SUPPORT DISK. NO PRIME ALARM OCCURRED DURING TESTING. THE INSULIN PUMP RECEIVED WITH BROKEN BATTERY CAP, CRACKED RESERVOIR TUBE LIP, BROKEN BATTERY TUBE THREADS, CRACKED CASE AT THE DISPLAY WINDOW CORNER, MINOR SCRATCHES ON LCD WINDOW, CRACKED LCD WINDOW, SCRATCHED RESERVOIR TUBE WINDOW, BROKEN BELT CLIP SLOT, AND CRACKED RESERVOIR TUBE.

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT THE INSULIN PUMP ALARMED WHILE PRIMING. THE BLOOD GLUCOSE READING WAS 132 MG/DL. THE CUSTOMER REPORTED THAT THE INSULIN PUMP WAS NOT DROPPED OR BUMPED PRIOR TO THE ALARM. THE DRIVE SUPPORT CAP WAS STICKING OUT. THE CUSTOMER WAS ADVISED TO DISCONTINUE USE OF THE INSULIN PUMP AND NO REVERT TO A BACK UP PLAN PER A HEALTH CARE PRACTITIONER'S INSTRUCTIONS. THE CUSTOMER WAS ADVISED THAT THE INSULIN PUMP WOULD BE REPLACED AND AGREED TO RETURN THE PRODUCT FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
325213 PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP INSULIN INFUSION PUMP / SENSOR AUGMENTED OYC MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-723NAS

Patients

Seq Age Sex Outcome Treatment
1 33 YR